Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting. [electronic resource]
Producer: 20140417Description: 615-22 p. digitalISSN:- 2040-2058
- Adult
- Alkynes
- Anti-HIV Agents -- adverse effects
- Antiretroviral Therapy, Highly Active
- Benzoxazines -- adverse effects
- CD4 Lymphocyte Count
- CD4-Positive T-Lymphocytes -- drug effects
- Cohort Studies
- Comorbidity
- Cyclopropanes
- Female
- HIV Infections -- drug therapy
- HIV-1 -- drug effects
- Humans
- Male
- Middle Aged
- Mycobacterium tuberculosis -- immunology
- Nevirapine -- adverse effects
- Proportional Hazards Models
- Risk Factors
- Survival Analysis
- Tuberculosis, Pulmonary -- etiology
- Uganda -- epidemiology
- Viral Load -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.